期刊文献+

苯磺贝他斯汀片联合玉屏风颗粒治疗慢性荨麻疹的疗效分析

Efficacy of Betahistine besilate tablets combined with Yupingfeng granule in the treatment of chronic urticaria
在线阅读 下载PDF
导出
摘要 目的观察苯磺贝他斯汀片联合玉屏风颗粒治疗慢性荨麻疹的临床疗效。方法选取2019年6月—2021年6月于南丰县疾病预防控制中心门诊部就诊的72例慢性荨麻疹患者,按治疗方式分为治疗组和对照组,各36例。对照组采用苯磺贝他斯汀片治疗,治疗组采用苯磺贝他斯汀片联合玉屏风颗粒治疗,疗程均为12周。比较2组患者的治疗效果、不良反应和复发情况。结果治疗8周及12周时2组患者的症状积分下降较明显,治疗组症状积分均明显低于对照组,差异均有统计学意义(P<0.05)。疗程结束后治疗组治疗总有效率为94.44%,高于对照组的72.22%,差异有统计学意义(P<0.05)。2组患者在治疗过程中均未出现严重不良反应。疗程结束时随访,治疗组慢性荨麻疹复发率为14.71%,明显低于对照组61.54%,差异有统计学意义(P<0.05)。结论运用苯磺贝他斯汀片联合玉屏风颗粒治疗慢性荨麻疹,临床疗效显著,复发率低,安全性较好。 Objective To observe the clinical effect of Betahistine besilate tablets with Yupingfeng granule combined in the treatment of chronic urticaria.Methods A total of 72 patients with chronic urticaria who visited the outpatient department of Nanfeng County Center for Disease Control and Prevention from June 2019 to June 2021 were selected and divided into treatment group and control group according to the research method,with 36 cases in each group.The control group was treated with Betahistine besilate tablets,and the treatment group was treated with Betahistine besilate tablets combined with Yupingfeng granule.The course of treatment was 12 weeks.The therapeutic effect,adverse reaction and recurrence of the two groups were observed.Results After 8 and 12 weeks of treatment,the symptom scores in the treatment group were significantly lower than those in the control group(P<0.05).After the end of the treatment course,the total effective rate of the treatment group was 94.44%,compared with 72.22%in the control group,significant difference was observed between two groups(P<0.05).There were no serious adverse reactions during treatment in two groups.At the end of treatment course,the recurrence rate of chronic urticaria in the treatment group was 14.71%,significantly lower than 61.54%in the control group,and the difference was statistically significant(P<0.05).Conclusion Betahistine besilate tablets with Yupingfeng granule combined in the treatment of chronic urticaria have significant clinical effect,low recurrence rate and good safety.
作者 付兰红 黄贵义 Fu Lanhong;Huang Guiyi(Nanfeng County Center for Disease Control and Prevention,Fuzhou,Jiangxi 344500)
出处 《基层医学论坛》 2023年第34期125-127,共3页 The Medical Forum
关键词 苯磺贝他斯汀片 玉屏风颗粒 慢性荨麻疹 Betahistine besilate tablets Yupingfeng granule Chronic urticaria
  • 相关文献

参考文献9

二级参考文献79

  • 1徐素平.咪唑斯汀联合曲尼司特治疗慢性荨麻疹疗效观察[J].皮肤病与性病,2004,26(3):30-31. 被引量:11
  • 2沈辉,刘海琴.左旋西替利嗪治疗慢性荨麻疹疗效观察[J].临床皮肤科杂志,2006,35(5):330-331. 被引量:33
  • 3李丽,赵跃然,王春霞.瘦素的免疫调节作用及信号转导研究进展[J].现代免疫学,2007,27(1):77-80. 被引量:7
  • 4荨麻疹诊疗指南(2007版)[J].中华皮肤科杂志,2007,40(10):591-593. 被引量:214
  • 5钟华,郝飞.荨麻疹的病理生理与临床[J].中华皮肤科杂志,2007,40(10):652-654. 被引量:69
  • 6Hashimoto T,Ishii N,Hamada T,et al. Effects of olopatadine hydrochloride, a histamine H1 receptor antagonist, on histamine - induced skin responses [ J ]. Dermatology Research and Practice, 2010,10(1) :l.
  • 7Kobayashi M, Kabashima K, Nakamura M, et al. Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human ke- ratinocytes [ J ]. Skin Pharmacol Physiol,2009,22 ( 1 ) :45.
  • 8Immunology Group of Chinese Society of Dermatology. Guidelines for the diagnosis and treatment of urticaria in China (2014) [J]. Chin J Dermatol, 2014, 47 (7): 514-516. DOI: 10.3760/cma.j.issn. 0412-4030.2014.07.019.
  • 9Chinese Society of Dermatology. Guidelines for the diagnosis and treatment of urticaria ( 2007 ) [ J ]. Chin J Dermatol, 2007, 40 (10): 591-593. DOI: 10.3760/j.issn.0412-4030.2007.10.001.
  • 10Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/ EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update [J]. Allergy, 2014, 69 (7): 68-887.

共引文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部